FDA User Fee Revised Models Urged By Consumer Groups
This article was originally published in The Tan Sheet
Executive Summary
FDA should charge "consulting fees" for the advice it provides drug manufacturers, Permanente Medical Group Associate Executive Director Sharon Levine, MD, suggested during a Dec. 7 FDA public meeting on the Prescription Drug User Fee Act